The F1 ATP synthetase beta-subunit: a major yeast novobiocin binding protein.
Novobiocin affects DNA metabolism in both prokaryotes and eukaryotes, resulting in cell death. In prokaryotes, the drug is a specific inhibitor of DNA gyrase, a type II topoisomerase that can be purified on a novobiocin-Sepharose column. The yeast type II topoisomerase is neither the biochemical, nor the genetic target of the antibiotic. We have purified the major yeast novobiocin binding proteins and identified one of them as the beta-subunit of the yeast mitochondrial F1 ATP synthetase, a protein highly conserved throughout evolution. The inactivation of this protein might explain the toxic effects of novobiocin on higher eukaryotic cells.
Jenkins
J R
JR
Department of Genetics, University of Leicester, England.
Pocklington
M J
MJ
Orr
E
E
D000595:Amino Acid Sequence; D000818:Animals; D000908:Antibodies, Fungal / Q000096:biosynthesis; D015153:Blotting, Western; D002352:Carrier Proteins / Q000378:metabolism*; D002417:Cattle; D002645:Chickens; D002846:Chromatography, Affinity; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004926:Escherichia coli / Q000201:enzymology / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006801:Humans; D008322:Mammals; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology*; D008969:Molecular Sequence Data; D009675:Novobiocin / Q000378:metabolism*; D006180:Proton-Translocating ATPases / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000201:enzymology*; D013045:Species Specificity; D014407:Tumor Cells, Cultured
D000908:Antibodies, Fungal; D002352:Carrier Proteins; D009675:Novobiocin; D006180:Proton-Translocating ATPases; D004250:DNA Topoisomerases, Type II